Tada K - Search Results

1

Dual inhibition of the mTORC1 and mTORC2 signaling pathways is a promising therapeutic target for adult T-cell leukemia.

Kawata T, Tada K, Kobayashi M, Sakamoto T, Takiuchi Y, Iwai F, Sakurada M, Hishizawa M, Shirakawa K, Shindo K, Sato H, Takaori-Kondo A. Kawata T, et al. Among authors: tada k. Cancer Sci. 2018 Jan;109(1):103-111. doi: 10.1111/cas.13431. Epub 2017 Nov 22. Cancer Sci. 2018. PMID: 29077243 Free PMC article.

2

APOBEC3B can impair genomic stability by inducing base substitutions in genomic DNA in human cells.

Shinohara M, Io K, Shindo K, Matsui M, Sakamoto T, Tada K, Kobayashi M, Kadowaki N, Takaori-Kondo A. Shinohara M, et al. Among authors: tada k. Sci Rep. 2012;2:806. doi: 10.1038/srep00806. Epub 2012 Nov 13. Sci Rep. 2012. PMID: 23150777 Free PMC article.

3

Defining HIV-1 Vif residues that interact with CBFβ by site-directed mutagenesis.

Matsui Y, Shindo K, Nagata K, Io K, Tada K, Iwai F, Kobayashi M, Kadowaki N, Harris RS, Takaori-Kondo A. Matsui Y, et al. Among authors: tada k. Virology. 2014 Jan 20;449:82-7. doi: 10.1016/j.virol.2013.11.004. Epub 2013 Nov 26. Virology. 2014. PMID: 24418540 Free PMC article.

4

CKIP-1 is an intrinsic negative regulator of T-cell activation through an interaction with CARMA1.

Sakamoto T, Kobayashi M, Tada K, Shinohara M, Io K, Nagata K, Iwai F, Takiuchi Y, Arai Y, Yamashita K, Shindo K, Kadowaki N, Koyanagi Y, Takaori-Kondo A. Sakamoto T, et al. Among authors: tada k. PLoS One. 2014 Jan 17;9(1):e85762. doi: 10.1371/journal.pone.0085762. eCollection 2014. PLoS One. 2014. PMID: 24465689 Free PMC article.

5

Abacavir, an anti-HIV-1 drug, targets TDP1-deficient adult T cell leukemia.

Tada K, Kobayashi M, Takiuchi Y, Iwai F, Sakamoto T, Nagata K, Shinohara M, Io K, Shirakawa K, Hishizawa M, Shindo K, Kadowaki N, Hirota K, Yamamoto J, Iwai S, Sasanuma H, Takeda S, Takaori-Kondo A. Tada K, et al. Sci Adv. 2015 Apr 24;1(3):e1400203. doi: 10.1126/sciadv.1400203. eCollection 2015 Apr. Sci Adv. 2015. PMID: 26601161 Free PMC article.

6

HTLV-1 bZIP factor suppresses TDP1 expression through inhibition of NRF-1 in adult T-cell leukemia.

Takiuchi Y, Kobayashi M, Tada K, Iwai F, Sakurada M, Hirabayashi S, Nagata K, Shirakawa K, Shindo K, Yasunaga JI, Murakawa Y, Rajapakse V, Pommier Y, Matsuoka M, Takaori-Kondo A. Takiuchi Y, et al. Among authors: tada k. Sci Rep. 2017 Oct 9;7(1):12849. doi: 10.1038/s41598-017-12924-0. Sci Rep. 2017. PMID: 28993637 Free PMC article.

7

HTLV-1 bZIP factor impairs DNA mismatch repair system.

Sakurada-Aono M, Sakamoto T, Kobayashi M, Takiuchi Y, Iwai F, Tada K, Sasanuma H, Hirabayashi S, Murakawa Y, Shirakawa K, Sakamoto C, Shindo K, Yasunaga JI, Matsuoka M, Pommier Y, Takeda S, Takaori-Kondo A. Sakurada-Aono M, et al. Among authors: tada k. Biochem Biophys Res Commun. 2023 May 21;657:43-49. doi: 10.1016/j.bbrc.2023.03.049. Epub 2023 Mar 21. Biochem Biophys Res Commun. 2023. PMID: 36972660 Free PMC article.

8

Allogeneic bone marrow transplantation for therapy-related acute lymphocytic leukemia after autologous hematopoietic stem cell transplantation for multiple myeloma.

Konishi Y, Tada K, Nishi K, Imada K. Konishi Y, et al. Among authors: tada k. Ann Hematol. 2016 Oct;95(10):1739-40. doi: 10.1007/s00277-016-2762-3. Epub 2016 Jul 30. Ann Hematol. 2016. PMID: 27473192 No abstract available.

9

[Autologous peripheral blood stem cell transplantation for treating primary central nervous system lymphoma: a single-center retrospective study].

Okubo Y, Kaneko H, Shimizu T, Nomura R, Hyuga M, Mitsuyoshi T, Tada K, Ukyo N, Mizutani C, Hatanaka K, Imada K. Okubo Y, et al. Among authors: tada k. Rinsho Ketsueki. 2018;59(1):33-39. doi: 10.11406/rinketsu.59.33. Rinsho Ketsueki. 2018. PMID: 29415935 Japanese.

10

Effectiveness and safety of R-GCD (rituximab, gemcitabine, carboplatin, and dexamethasone) for transplant-ineligible relapse/refractory diffuse large B-cell lymphoma and grade 3a follicular lymphoma: a retrospective analysis comparing with R-GDP (rituximab, gemcitabine, cisplatin, and dexamethasone).

Naka R, Tada K, Kaneko H, Nagata O, Tashima M, Mizutani C, Imada K. Naka R, et al. Among authors: tada k. Leuk Lymphoma. 2022 Jun;63(6):1508-1511. doi: 10.1080/10428194.2022.2032040. Epub 2022 Feb 2. Leuk Lymphoma. 2022. PMID: 35105261 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,240 results

Search Page

Filters